immutep (asx:imm, nasdaq:immp) global webcast presentation at sitc 2022
Published 1 year ago • 283 plays • Length 52:08
Download video MP4
Download video MP3
Similar videos
-
56:38
immutep (asx:imm, nasdaq:immp) webcast for tacti-002 data presented at asco 2022 - 10 jun 2022
-
46:43
immutep limited (asx:imm, nasdaq:immp) - webcast presentation for cohort b of tacti-003 trial
-
6:25
immutep (asx:imm, nasdaq:immp) discusses a transformative year for lag-3 therapies
-
16:06
immutep (asx:imm) - webinar presentation
-
15:49
immutep (asx:imm) - webinar presentation
-
5:42
immutep (asx:imm, nasdaq:immp) receives fast track designation from fda - october 12, 2022
-
7:09
immutep (asx:imm, nasdaq:immp) reports 71.4% response rate for lung cancer therapy, october 31, 2023
-
12:28
immutep (asx:imm, nasdaq:immp) ceo marc voigt provides an update on clinical trials
-
7:58
immutep : immutep’s leading position within the lag-3 competitive landscape, 04 may 2021
-
17:30
18 minutes with immutep ceo marc voigt
-
4:44
immutep (asx:imm, nasdaq:immp) - innovative cancer therapies
-
16:07
immutep (asx:imm) - webinar presentation
-
5:10
immutep (asx:imm, nasdaq:immp) reports first subject dosed in autoimmune disease study
-
47:53
immutep (asx:imm, nasdaq:immp) tacti-003 results, june 2024
-
4:40
immutep (asx:imm, nasdaq:immp) announces encouraging trial data for lung cancer therapy
-
50:22
immutep (asx:imm, nasdaq:immp) esmo congress results webinar, 23 october 2023
-
1:14:06
immutep (asx:imm) sitc 2021 results - management update
-
27:17
immutep limited (asx:imm, nasdaq:immp) - fireside chat with immutep limited
-
7:17
immutep (asx:imm, nasdaq:immp) delivering strong data in first-line non-small cell lung cancer
-
6:59
immutep (asx:imm; nasdaq: immp) global leader in development of lag 3 gene immuno-therapies
-
10:55
immutep (asx:imm) presentation, fnn investor event, may 2022
Clip.africa.com - Privacy-policy